Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA2743 BarbadinSummary: Barbadin is a selective interaction inhibitor with values of 19.1 μM and 15.6 μM for β-arrestin1 and β-arrestin2, respectively. -
BA2744 TVB-3166Summary: TVB-3166 is an orally effective, reversible and selective fatty acid synthase inhibitor with 42 nM and 81 nM for FASN and cellular palmitate synthesis, respectively. -
BA2745 OctreotideSummary: Octreotide (SMS201-995) is a growth inhibitor receptor agonist and synthetic octapeptide growth inhibitor analog. -
BA2746 Deferoxamine5 CitationSummary: Deferoxamine (DeferoxamineB) is an iron chelator (binding Fe(III) and many other metal cations) that is widely used to reduce iron accumulation and deposition in tissues. -
BA2747 MRT-2359Summary: MRT-2359 is a potent, orally active and selective degrader (>30nM and <300nM) that specifically induces protein translation-dependent apoptosis. -
BA2748 DegarelixSummary: Degarelix is a competitive, reversible gonadotropin-releasing hormone receptor antagonist. -
BA2749 CWI1-2Summary: CWI1-2 is an inhibitor. -
BA2750 MS177Summary: MS177 is an effective and fast acting degradant. -
BA2751 CTBSummary: CTB is an activator of p300 histone acetyltransferase. -
BA2752 AC-4-130Summary: AC-4-130 is a potent structural domain inhibitor.

